These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768 [TBL] [Abstract][Full Text] [Related]
8. [Combined antihypertensive and antilipemic therapy as one of the pillars in the poly-pharmacologic preventive strategy for patients with high cardiovascular risk]. Kékes E Orv Hetil; 2008 Sep; 149(39):1827-37. PubMed ID: 18805771 [TBL] [Abstract][Full Text] [Related]
9. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
10. Long-term survival following the development of heart failure in an elderly hypertensive population. Sahle BW; Owen AJ; Wing LMH; Beilin LJ; Krum H; Reid CM; Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28859261 [TBL] [Abstract][Full Text] [Related]
11. The editor's roundtable: Acute decompensated heart failure. Friedewald VE; Gheorghiade M; Yancy CW; Young JB; Roberts WC Am J Cardiol; 2007 Jun; 99(11):1560-7. PubMed ID: 17531581 [No Abstract] [Full Text] [Related]
12. Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL). Holme I; Strandberg TE; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR; Atherosclerosis; 2009 Aug; 205(2):522-7. PubMed ID: 19327776 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study. Akhabue E; Vu TT; Vaidya A; Michos ED; de Boer IH; Kestenbaum B; Allison M; Szklo M; Ouyang P; Yancy CW; Wolf M; Isakova T; Carnethon MR Am J Hypertens; 2019 Jan; 32(1):18-25. PubMed ID: 30256890 [TBL] [Abstract][Full Text] [Related]
14. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R; Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474 [TBL] [Abstract][Full Text] [Related]
15. Assessment of drug therapy management and the prevalence of heart failure in a managed care population with hypertension. Jackson JH; Frech F; Ronen R; Mullany L; Lennert B; Jhaveri V J Manag Care Pharm; 2004; 10(6):513-20. PubMed ID: 15548123 [TBL] [Abstract][Full Text] [Related]
16. The Transition From Hypertension to Heart Failure: Contemporary Update. Messerli FH; Rimoldi SF; Bangalore S JACC Heart Fail; 2017 Aug; 5(8):543-551. PubMed ID: 28711447 [TBL] [Abstract][Full Text] [Related]
17. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis. Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR; Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636 [TBL] [Abstract][Full Text] [Related]
18. [Prevention and treatment of congestive heart failure in diabetic patients]. Anguita Sánchez M Rev Esp Cardiol; 2002 Oct; 55(10):1083-7. PubMed ID: 12383394 [TBL] [Abstract][Full Text] [Related]
19. Do statins prevent heart failure in patients after myocardial infarction? Ducharme A; Rouleau JL Curr Heart Fail Rep; 2004 Dec; 1(4):156-60. PubMed ID: 16036039 [TBL] [Abstract][Full Text] [Related]